Federal contract receipt
$396,999,520 from Department of Health and Human Services to GENENTECH USA, INC
EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING TAMIFLU 75MG CAPSULES (NDC 0004-0800-85) AND TAMIFLU 30MG CAPSULES (NDC 0004-0802-85)
Signals
Full and openLarge awardMulti-year performance
Office of Federal Procurement Policy
Public Spend Intelligence - sledai.com
Award #CONT_AWD_75A50324F80002_7505_36F79723D0219_3600
Signed2023-11-17
VendorGENENTECH USA, INC
PlaceCA
EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING TAMIFLU 75MG CAPSULES (NDC 0004-0800-85) AND TAMIFLU 30MG CAPSULES (NDC 0004-0802-85)
Total obligated$396,999,520.00
PoP Start
2023-11-17
PoP End
2025-11-16
COMPETED
Awarded on 2023-11-17
Vendor
GENENTECH USA, INC
Agency
Department of Health and Human Services
Category
PHARMACEUTICAL PREPARATION MANUFACTURING
Place
CA
© 2025 Sled AI Inc. All rights reserved.